1 |
M. Singh and D.T. O'Hagan, Recent advances in vaccine adjuvants, Phann. Res., 19, 715-728 (2002)
DOI
|
2 |
M. Zahiru, L Khan, lP. Opdebeeck and LG. Tucker, Immunopotentiation and delivery systems for antigens for single-step immunization: Recent trends and progress, Phann. Res., 11,2-10 (1994)
DOI
|
3 |
A. Moore, P. McGuirk, S. Adams, We. Jones, lP. McGee, D.T. OHagan and KH. Mills, Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and Thl cells, Vaccine, 13, 1741-1749 (1995)
DOI
ScienceOn
|
4 |
EJ. Frazza and E.E. Schmitt, A new absorbable study, J. Biomed. Mater. Res. Symp., 1, 43-52 (1971)
|
5 |
lM. Brady, D.E. Cutright, R.A Miller and G.e. Battestone, Resorption rate, route of elimination and ultra structure of the implant site of polylactic acid in abdominal wall of the rat, J. Biomed. Mater. Res., 7, 155-173 (1973)
DOI
ScienceOn
|
6 |
J. Hanes, J. L. Cleland and R Langer, New advances in microsphere-based single-dose vaccines, Adv. Drug Deliv: Rev., 28, 97-119 (1997)
DOI
ScienceOn
|
7 |
G.F.A Kersten, D. Donders, A Akkermans and E.C.Beuvery, Single shot vaccine with tetanus toxoid in biodegradable microsphere protects mice despite acidinduced denaturation of the antigen, Vaccine, 14, 1627-1632 (1996)
DOI
ScienceOn
|
8 |
D.T. OHagan, D. Rahman, lP. McGee, H. Jeffery, M.C.Davies, P. Williams, S.S. Davis and SJ. Challacombe, Biodegradable microparticles as controlled release antigen delivery systems, Immunology, 73, 239-242 (1991)
|
9 |
M. Singh, A. Singh and G.P. Talwar, Controlled delivery of diphtheria toxoid using biodegradable poly(D,L-lactide) microcapsules, Pharm. Res., 8, 958-961 (1991)
DOI
ScienceOn
|
10 |
M.J. Alonso, S. Cohen, T.G. Park, RK Gupta, G.R. Siber and R Langer, Determinants of release rate of tetanus vaccine from polyester microspheres, Phann. Res., 10, 945-953 (2003)
|
11 |
D.E Nixon, C. Hioe, P.D. Chen, Z. Bian, P. Kuebler, M.L. Li, H. Aiu, X.N. Li, M. Singh, l Richardson, P. Mcgee, T. Zamb, W Koff, cv Wang and D.T. OHagan, Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity, Vaccine, 14, 1523-1530 (1996)
DOI
ScienceOn
|
12 |
S. Wright and L. Huang, Antibody-directed liposomes as drug delivery vehicles, Adv. Drug Deliv. Rev., 3, 343-389 (1989)
DOI
ScienceOn
|
13 |
N. van Rooijen, Liposomes as carrier and immunoadjuvant of vaccine antigens, Adv. Biotechnol. Process, 13, 255-279 (1990)
|
14 |
CR. Alving, Liposomes as carriers of antigens and adjuvants, J. Immunol. Methods, 140, 1-13 (1991)
DOI
ScienceOn
|
15 |
Kl Maloy, AM. Donachie, D.T. OHagan and AM. Mowat, Induction of mucosal and systemic immune responses by immunization with albumin entrapped in poly(lactide-co-glycloide) microparticles, Immunology, 81, 661-667 (1994)
|
16 |
P. Johansen, Y Men, R Audran, G. Corradin, H.P. Merkle and B. Gander, Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives, Pharm. Res., 15, 1103-1110 (1998)
DOI
ScienceOn
|
17 |
R. Audran, Y. Men, P. Johansen, B. Gander and G. Corradin, Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents, Pharm. Res., 15, 1111-1116 (1998)
DOI
ScienceOn
|
18 |
D.K.L. Xing, D.T. Crane, B. Bolgiano, MJ. Corbel, e. Jones and D. Sesardic, Physicochemical and immunological studies on the stability of free and microsphere-encapsulated tetanus toxoid in vitro, Vaccine, 14, 1205-1213 (1996)
DOI
ScienceOn
|
19 |
C.D. Partidos, P. Vohra, D. Jones, G. Farrar and MW. Steward, CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles, J. Immunol. Methods, 206, 143-151 (1997)
DOI
ScienceOn
|
20 |
C. Thomasin, G. Corradin, Y. Men, H.P. Merkle and B. Gander, Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres : Importance of polymer degradation and antigen release for immune response, J. Control. Release, 41, 131-145 (1996)
DOI
ScienceOn
|
21 |
V.R. Sinha and A Trehan, Biodegradable microspheres for protein delivery, J. Control. Release, 90, 261-280 (2003)
DOI
ScienceOn
|
22 |
M. Higaki, Y. Azechi, T. Takase, R Igarashi, S. Nagahara, A Sano, K Fujiko, N. Nakagawa, e. Aizawa and Y. Mizushima, Collagen minipellet as a controlled release delivery system for tetanus and diphtheria toxoid, Vaccine, 19, 3091-3096 (2001)
DOI
ScienceOn
|
23 |
M. Diwan, T.K Khar and G.P. Talwar, Tetanus toxoid loaded preformed microspheres of crossed linked dextran, Vaccine, 19, 3853-3859 (2001)
DOI
ScienceOn
|
24 |
T.G. Park, W Lu and G. Crotts, Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation on protein encapsulated poly(D,Llactic acid-eo-glycolic acid) microspheres, 1. Control. Release, 33, 221-235 (1995)
|
25 |
D.T. OHagan, 1.P. McGee, M. Lindblad and J. Holmgren, Cholera toxin B subunit retains antigenicity and immunogenicity following encapsulation in biodegradable microparticles, Int. J. Pharm., 119, 251-255 (1995)
DOI
ScienceOn
|
26 |
D.T. O'Hagan, J.P. McGee, R Boyle, D. Gumaer, X.M. Li, B. Potts, C.Y. Wang and We. Koff, The preparation, characterization and pre-clinical evaluation of an orally administered HIV-1 vaccine, consisting of a branched peptide immunogen entrapped in controlled release microparticles, J. Control. Release, 36, 75-84 (1995)
DOI
ScienceOn
|
27 |
A.B. Sasiak, B. Bolgiano, D.T. Crane, D.E Hockley, M.J.Corbel and D. Sesardic, Comparison of in vitro and in vivo methods to study stability of PLGA microencapsulated tetanus toxoid vaccines, Vaccine, 19, 694-705 (2001)
DOI
ScienceOn
|
28 |
lP. McGee, M. Singh, X.M. Li, H. Qui and D.T. OHagan, The encapsulation of a model protein in poly(lactide-coglycolide) microparticles of various sizes: an evaluation of process reproducibility, J. Microencap., 14, 197-203 (1997)
DOI
ScienceOn
|
29 |
lL. Cleland and A.lS. Jones, Stable formulations of ecombinant human growth hormone and interferon for microencapsulation in biodegradable microspheres, Phann. Res., 13, 1464-1475 (1996)
DOI
|
30 |
AK. Hilbert, U. Fritzsche and T. Kissel, Biodegradable microspheres containing influenza A vaccine: Immune response in mice, Vaccine, 17, 1065-1073 (1999)
DOI
ScienceOn
|
31 |
D.T. O'Hagan, M. Ugozzoli, J. Barackman, M. Singh, J.Kazzaz, K. Higgins, T.e. Vancott and G.S. Ott, Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1, Vaccine, 18, 1793-1801 (2000)
DOI
ScienceOn
|
32 |
D.T. O'Hagan, M. Singh and RK. Gupta, Poly(lactide-coglycolide) microparticles for the development of single-dose controlled-release vaccines, Adv. Drug Deliv. Rev., 32, 225-246 (1998)
DOI
ScienceOn
|
33 |
AM. Carcaboso, RM. Hernandez, M. Igartua, A.R Gascon, J.E. Rosas, M.E. Patarroyo and J.L. Pedraz, Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66, Int. J. Pharm., 260, 273-282 (2003)
DOI
ScienceOn
|
34 |
T.L. Bowersock, H. HogenEsch, M. Suckow, R.E. Porter, R Jackson, H. Park and K. Park, Oral vaccination with alginate microsphere systems, J. Control. Release, 39, 209-220 (1996)
DOI
ScienceOn
|
35 |
J.A. Reynolds, D.G. Harrington, ci, Crabbs, C.J. Peters and N.R. Di Luzio, Adjuvant activity of a novel metabolizable lipid emulsion with inactivated viral vaccines, Infect. Immun., 28, 937-943 (1980)
|
36 |
E.C. Lavelle, M.K. Yeh, A.G.A Coombes and S.S. Davis, The stability and immunogenicity of a protein antigen encapsulated in biodegradable micropartic1es based on blends of lactide polymers and polyethylene glycol, Vaccine, 17, 512-529 (1999)
DOI
ScienceOn
|
37 |
A , B. Villamayor, Y Guo, J. McIver and M.J.Alonso, Formulation strategies for the stabilization of tetanus toxoid in polytlactide-co-glycolide) microspheres, Int. J.Pharm., 185, 255-266 (1999)
DOI
ScienceOn
|
38 |
A.-C. Chang and R.K. Gupta, Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen, j. Pharm. Sci., 85, 129-132 (1996)
DOI
|
39 |
M. Brugh, J.D. Stone and H.W Lupton, Comparison of inactivated Newcastle disease viral vaccines containing different emulsion adjuvants, Am. J. Vet. Res., 44, 72-75 (1983)
|
40 |
W Lu and T.G. Park, Protein release from polytlactic-coglycolic acid) microspheres: protein stability problems, J. Pharm. Sci. Tech., 49, 13-19 (1995)
|
41 |
B. Baras, M.A Benoit and I. Gillard, Parameters influencing the antigen release from spray-dried poly(DL-lactide) microparticles, Int. J. Pharm., 200, 133-145 (2000)
DOI
ScienceOn
|
42 |
M. Murillo, C. Gamazo, M. Gofii, J. Irache and M. BlancoPrieto, Development of microparticles prepared by spraydrying as a vaccine delivery system against brucellosis, Int. J. Phann., 242, 341-344 (2002)
DOI
|
43 |
A.I. Bot, D.J. Smith, S. Bot, L. Dellamary, T.E. Tarara, S. Harders, W. Phillips, I.G. Weers and C.M. Woods, Receptormediated targeting of spray-dried lipid particles co-formulated with immunoglobulin and loaded with a prototype vaccine, Phann. Res., 18, 971-979 (2001)
DOI
|
44 |
D.H. Jones, B.W McBride and G.H. Farrar, Poly (lactide-coglycolide)microencapsulation of vaccine antigens, Biotechnology, 44, 29-36 (1996)
DOI
ScienceOn
|
45 |
C.G. Pitt, M.M. Gratzl, G.L. Kummel, J. Surles and A Schindler, Aliphatic polyesters, The degradation of poly(DLlactide) and their copolymers in vivo, Biomaterials, 2, 215224 (1981)
DOI
ScienceOn
|
46 |
R.S.R. Murthy, Biodegradable polymers: In Controlled and Novel Drug Delivery, N.K. Jain (Ed.), CBS Publishers and Distributors, New Delhi, India, pp. 27-51 (1997)
|
47 |
D.H. Lewis, Controlled release of bioactive agents from lactide/glycolide polymers: In Biodegradable Polymers as Drug Delivery System, Drugs and, M. Chasin, R and Langer (Eds.), Marcel Dekker, New York, U.S.A., pp. 9-41 (1990)
|
48 |
S. Takada, Y, Yamagata, M. Misaki, K. Taira and T. Kurokawa, Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique, J. Control. Release, 88, 229-242 (2003)
DOI
ScienceOn
|
49 |
R.K. Gupta, A.C. Chang, P. Griffin, Y,Y. Guo and G.R. Siber, Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid, Vaccine, 15, 672-678 (1997)
DOI
ScienceOn
|
50 |
R.S. Raghuvanshi, Y.K. Katare, K. Lalwani, M.M. Ali, O. Singh and AK. Panda, Improved immune response from biodegradable polymer particle entrapping tetanus toxoid by use of different immunization protocol and adjuvants, Int. J. Pharm., 245, 109-121 (2002)
DOI
ScienceOn
|
51 |
P. Johansen, E Estevez, R Zurbriggen, H.P. Merkle, R Gliick, G. Corradin and B. Gander, Towards clinical testing of a single-administration tetanus vaccine based on PLAlPLGA microspheres, Vaccine, 19, 1047-1054 (2001)
DOI
ScienceOn
|
52 |
R. Jalil and I.R Nixon, Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules : Problems associated with preparative techniques and release properties, J. Microencapsul., 7, 297-325 (1990)
DOI
|
53 |
T.L. Bowersock and S. Martin, Vaccine delivery to animals, Adv. Drug Deliv. Rev., 38, 167-194 (1999)
DOI
ScienceOn
|
54 |
T. Kissel, vx. Li, e. Volland, S. Gorich and R Koneberg, Parenteral protein delivery systems using biodegradable polyesters of ABA block structure, containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly (ethylene oxide) B blocks, J. Control. Release, 39, 315-326 (1996)
DOI
ScienceOn
|
55 |
Y. Ogawa, H. Okada, Y.Yamamoto and T. Shimamoto, A new technique to efficiently entrap leuprorelide acetate into microcapsules of poly(lactic acid) or copoly(lactic/glycolic) acid, Chern. Phann. Bull., 36, 1095-1108 (1988)
DOI
ScienceOn
|
56 |
K. Masters, Spray-drying fundamentals process stages and lay-outs: In Spray-drying handbook. Nsters K, (Ed.), Longman Scientific and Technical, Essex, Ll.K, pp. 23-66 (1994)
|
57 |
B. Baras, M. Benoit, O. Poulain-Godefroy, A Schacht, A Capron, I. Gillard and G. Riveau, Vaccine properties of antigens entrapped in microparticles produced by spraydrying technique and using various polyester polymers, Vaccine, 18, 1495-1505 (2000)
DOI
ScienceOn
|
58 |
D.T. O'Hagan, H. Jeffery and S.S. Davis, Long term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles, Vaccine, 11, 965-969 (1993)
DOI
ScienceOn
|
59 |
S. Cohen, T. Yoshioka, M. Lucarelli, L.H. Hwang and R Langer, Controlled delivery systems for protein based on poly(lactic/glycolic acid) microspheres, Pharm. Res., 8, 713-720 (1991)
DOI
ScienceOn
|
60 |
N. Clarke, K. OConnor and Z. Ramtoola, In fluence of formulation variables on the morphology of biodegradable microparticles prepared by spray-drying, Drug Dev. Ind. Phann., 24, 169-174 (1998)
DOI
ScienceOn
|
61 |
A.G.A. Coombes, M.K. Yeh, E.C. Lavelle and S.S Davis, The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method, J. Control. Release, 52, 311-320 (1998)
DOI
ScienceOn
|
62 |
M.K. Yeh, A.G.A. Coombes, P.G. Jenkins and S.S. Davis, A novel emulsification-solvent extraction technique for production of protein loaded biodegradable microparticles for vaccine and drug delivery, J. Control. Release, 33, 437-445 (1995)
DOI
ScienceOn
|
63 |
I.Y. Song, S.H. Song, WH. Song, S.W Cho and Y.W Choi, Particle size control of poly(lactide-co-glycolide) microspheres for oral antigen delivery system, J. Kor. Phann. Sci., 29, 315-321 (1999)
|
64 |
S.W Cho, S.H Song and Y.W Choi, Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin, Arch. Phann. Res., 23, 385-390 (2000)
DOI
ScienceOn
|
65 |
P. Johansen, B. Gander, H.P. Merkle and D. Sesardic, Ambiguities in the preclinical quality assessment of microparticulate vaccines, Trends Biotechnol., 18, 203-211 (2000)
DOI
ScienceOn
|
66 |
H. Rafati, E.C. Lavelle, AG.A. Coombes, S. Stolnik, J. Holland and S.S. Davis, The immune response to a modelantigen associated with PLG microparticles prepared using different surfactants, Vaccine, 15, 1888-1897 (1997)
DOI
ScienceOn
|
67 |
R. Nakaoka, Y. Inoue, Y Tabata and Y.Ikada, Size effect on the antibody production induced by biodegradable microspheres containing antigen, Vaccine, 14, 1251-1256 (1996)
DOI
ScienceOn
|
68 |
J.E. Rosas, J.L. Pedraz, RM. Hernandez, AR Gascon, M. Igartua, E Guzman, R Rodriguez, J. Cortes and M.E. Patarroyo, Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunization of SPf66 encapsulated in PLGA microspheres, Vaccine, 20, 1707-1710 (2002)
DOI
ScienceOn
|
69 |
M. Singh, X.-M. Li, H. Wang, J.P. McGee, T. Zamb, W. Koff, C.Y. Wang and D.T. O'hagan, Controlled release microparticles as a single dose diphtheria toxoid vaccine : Immunogenicity in small animal models, Vaccine, 16, 346-352 (1998)
DOI
ScienceOn
|
70 |
P. Johansen, L. Moon, H. Tamber, H.P. Merkle, B. Gander and D. Sesardic, Immunogenicity of single-dose diphtheria vaccines based on PLAlPLGA microspheres in guinea pigs, Vaccine, 28, 209-215 (2000)
|
71 |
M. Singh, X.-M. Li, H. Wang and D.T. O'Hagan, Immunogenicity and protection in small animal models with controlled-release tetanus toxoid microparticles as a singledose vaccine, Infect. Immun., 1716-1721 (1997)
|
72 |
D.T. O'Hagan, G.S. Ott and G.Y. Nest, Recent advances in vaccine adjuvants: The development of MF59 emulsion and polymeric microparticles, Molecular Medicine Today, 3, 6975 (1997)
DOI
ScienceOn
|
73 |
P. Johansen, Y. Men, H.P. Merkle and B. Gander, Revisiting PLAlPLGA microspheres: An analysis of their potential in parenteral vaccination, Eur. J. Phann. Biophann., 50, 129-146 (2000)
DOI
ScienceOn
|
74 |
T. Jung, W Kamm, A Breitenbach, K.-D. Hungerer, E. Hundt and T. Kissel, Tetanus toxoid loaded nanopartic1es from sulfobutylated poly(Vinyl Alcohol)-graft-poly(lactideco-glycolide): Evaluation of antibody response after oral and nasal application in mice, Pharm. Res., 18, 352-360 (2001)
DOI
ScienceOn
|
75 |
D.T. O'Hagan, H. Jeffery, MJJ. Roberts, lP. McGee and S.S.Davis, Controlled release microparticles for vaccine development, Vaccine, 9, 768-771 (1991)
DOI
ScienceOn
|
76 |
A.G.A Coombes, E.C. Lavelle, P.G. Jenkins and S.S. Davis, Single dose, polymeric, microparticle-based vaccines: The influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen, Vaccine, 14, 1429-1438 (1996)
DOI
ScienceOn
|
77 |
I. Jabbal-Gill, W Lin, P. Jenkins, P. Watts, M. Jimenez, L. mum, S.S. Davis, I.M. Wood, D. Major, P.D. Minor, X. Li, E.C. Lavelle and AG.A Coombes, Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines, Vaccine, 18, 238-250 (1999)
DOI
ScienceOn
|
78 |
P. Johanse, G. Corradin, H.P. Merkle and B. Gander, Release of tetanus toxoid from adjuvants and PLGA microspheres: How experimental set-up and surface adsorption fool the pattern, J. Control. Release, 56, 209-217 (1998)
DOI
ScienceOn
|
79 |
E-L. Mi, S.-S. Shyu, C.-T. Chen and J.-Y. Schoung, Porous chitosan microsphere for controlling the antigen release of Newcastle disease vaccine : preparation of antigen-adsorbed microsphere and in vitro release, Biomaterials, 20, 1603-1612 (1999)
DOI
ScienceOn
|
80 |
R.K. Gupta, H. Alroy, M.H. Alonso, R Langer and GR Siver, Chronic local tissue reactions, long term immunogenicity and immunologic proming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers, Vaccine, 15, 1716-1723 (1997)
DOI
ScienceOn
|
81 |
R.S. Raghuvanshi, O.M. Singh and AK. Panda, Formulation and characterization of immunoreactive tetanus toxoid biodegradable polymer particles, Drug Delivery, 8, 99-106 (2001)
DOI
ScienceOn
|
82 |
T. lung, R. Koneberg, K.-D. Hungerer and T. Kissel, Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)-and ABA-triblock-copolymers:immune response in mice, Int. J. Pharm., 234, 75-90 (2002)
DOI
ScienceOn
|
83 |
P. Johansen, H. Tamver, H.P. Merkle and B. Gander, Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA-PLGAs, Eur. J. Pharm. Biopharm., 47, 193-201 (1999)
DOI
ScienceOn
|
84 |
M. Tovio, S.P. Schwendeman, Y Guo, J. McIver, R Langer and MJ. Alonso, Improved immunogenicity of a core-coated tetanus toxoid delivery system, Vaccine, 18, 618-622 (2000)
|
85 |
Y.X., Li, T. Kissel, Synthesis and properties of biodegradable ABA triblock copolymers consisting of poly (L-lactic acid) or poly(L-lactic-co-glycolic acid) A-blocks attached to central poly(oxyethylene) B-blocks, J. Controll. Release, 27, 247-257 (1993)
DOI
ScienceOn
|
86 |
A.G.A Coombes, S. Tasker, M. Lindblad, l Holmgren, K.Hoste, V. Toncheva, E. Schacht, M.e. Davies and L. Illum, Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments, Biomaterials, 18, 1153-1161 (1997)
DOI
ScienceOn
|
87 |
R.K Gupta, Ae. Chang and GR Siber, Biodegradable polymer microspheres as vaccine adjuvants and delivery systems, Dev. Biol. Stand., 92, 63-78 (1998)
|
88 |
S. Sharpe, T. Hanke, A Tinsley-Bown, M. Dennis, S. Dowall, A McMichael and M. Cranage, Mucosal immunization with PLGA-microencapsulated DNA primes a SlY-specific CTL response revealed by boosting with cognate recombinant modified vaccine virus Ankara, Virology, 313, 13-21 (2003)
DOI
ScienceOn
|
89 |
M. Igartua, R.M. Hernandez, A. Esquisabel, A.R., Gascon, M.B. Calvo and J.L. Pedraz, Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres, J. Control. Release, 56, 63-73 (1998)
DOI
ScienceOn
|
90 |
D.K. Xing, K. McLellan, M.J. Corbel and D. Sesardic, Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres, Biologicals, 24, 57-65 (1996)
DOI
ScienceOn
|
91 |
J.S. Moynihan, D.H. Jones, G.H. Farrar and e.RA Howard, A novel microencapsulated peptide vaccine against hepatitis B, Vaccine, 19, 3292-3300 (2001)
DOI
ScienceOn
|
92 |
M. Ying, e. Thomasin, H.P. Merkle, B. Gander and G. Corradin, A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminumhydroxide, Vaccine, 13, 683-689 (1995)
DOI
ScienceOn
|
93 |
H.M. Vordermeier, A.G.A Coombes, P. Jenkins, J.P. McGee, D.T. O'Hagan, S.S. Davis and M. Singh, Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLGA microparticles, Vaccine, 13, 1576-1582 (1995)
DOI
ScienceOn
|
94 |
K.F. Griffin, BR Conway, H.O. Alpar and ED. Williamson, Immune responses to V antigen of Yersinia pestis coencapsulated with IFN-: Effect of dose and formulation, Vaccine, 16, 517-521 (1998)
DOI
ScienceOn
|
95 |
M. Singh, lP. McGee, XM. Li, W Koff, T. Zamb, C.Y Wang and D.T. O'Hagan, Biodegradable microparticles with an entrapped branched octameric peptide as a controlledrelease HIV-l vaccine, J. Pharm. Sci., 86, 1229-1233 (1997)
DOI
ScienceOn
|
96 |
R.K Gupta, A-e. Chang, P. Griffin, R Rivera and G.R Siber, In vivo distribution of radioactivity in micea after injection of biodegradable polymer microspheres containing tetanus toxoid, Vaccine, 14, 1414-1416 (1996)
|
97 |
M. Singh, XM. Li, lP. McGee, T. Zamb, W Koff, C.Y Wang and D.T. O'Hagan, Controlled release microparticles as a single dose hepatitis B vaccine: Evaluation of immunogenicity in mice, Vaccine, 15, 475-481 (1997)
DOI
ScienceOn
|
98 |
lE. Butler and RG. Hamilton, Quantitation of specific antibodies: Methods of expression, standard, solid-phase considerations, and specific applications: In Immunochemistry of Solid-phase Imunoassays, lE. Butler (Ed.), CRC Press, Boca Raton, Florida, U.S.A., pp. 173-198 (1991)
|
99 |
S. Kodihalli, D.L. Kobasa and RG. Webster, Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines, Vaccine, 18, 2592-2599 (2000)
DOI
ScienceOn
|
100 |
E. Fattal, S. Pecquet, P. Couvreur and A Andremont, Biodegradable microparticles for the mucosal delivery of antibacterial and dietary antigens, Int. J. Pharm., 242, 15-24 (2002)
DOI
ScienceOn
|
101 |
Y. Changhong, WL. Rill, R Malli, J. Hewetson, H. Naseem, R. Tammariello and M. Kende, Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid, Vaccine, 14, 1031-1038 (1996)
DOI
ScienceOn
|
102 |
H.C.J. Ertl, I. Varga, Z.Q. Xiang, K. Kaiser, L. Stephens and L. Otvos Jr., Poly(DL-lactide-co-glycolide) microspheres as carriers for peptide vaccines, Vaccine, 14, 879-885 (1996)
DOI
ScienceOn
|
103 |
K.B. Walker, D.K. Xing, D. Sesardic and MJ. Corbel, Modulation of the immune response to tetanus toxoid by polylactide-polyglycolide microspheres, Dev. Biol. Stand., 92, 259-267 (1998)
|
104 |
M. Helliwell, The use of bioadhesives in targeted delivery within the gastrointestinal tract, Adv. Drug Deliv. Rev; 11, 221-251 (1993)
DOI
ScienceOn
|